Lung cancer vaccine CIMAvax-EGF stands out at BioHabana 2022
Havana, Apr 28 (Prensa Latina) The clinical trial results with Cuban lung cancer vaccine CIMAvax-EGF on Thursday stands out in the theoretical sessions of the BioHabana 2022 International Congress, scheduled until Friday, April 29.
Source: plenglish.com